PharmaNova Inc. is a privately held, specialty drug development company founded on the re-purposing and enhancement of known drugs using our proprietary nanoparticle technology platform and other complementary formulation and drug delivery technologies.

•       Our platform nanoparticle technology provides amorphous nanoparticles of precisely controlled size, shape and distribution.

•       We focus our internal programs on low-risk, fast-to-market products, to generate revenues via partnering and out-licensing worldwide.  We also offer the opportunity for the contractual preparation of nanoparticulate materials for pharmaceutical clients.

•       Our pipeline includes medically needed high value global products in Women’s Health, and the adjacent areas of oncology, urology, and anti-infectives:

o   non-hormonal treatments for vasomotor instability e.g. hot flushes of the menopause and of the treatments for prostate and breast cancers.

o   nanoparticulate chemotherapeutics and anti-infectives